Display options
Cite
Eskandarieh S, Nikfarjam A, Tarjoman T, et al. Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment. Iran J Public Health. 2013;42(6):588-93
Eskandarieh, S., Nikfarjam, A., Tarjoman, T., Nasehi, A., Jafari, F., & Saberi-Zafarghandi, M. B. (2013). Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment. Iranian journal of public health, 42(6), 588-93.
Eskandarieh, Sharareh, et al. "Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment." Iranian journal of public health vol. 42,6 (2013): 588-93.
Eskandarieh S, Nikfarjam A, Tarjoman T, Nasehi A, Jafari F, Saberi-Zafarghandi MB. Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment. Iran J Public Health. 2013 Jun 01;42(6):588-93. eCollection 2013. PMID: 23967426; PMCID: PMC3744255.
Copy Download .nbib Format: NLM
Share it on

Iran J Public Health. 2013 Jun 01;42(6):588-93. eCollection 2013.

Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment.

Iranian journal of public health

Sharareh Eskandarieh, Ali Nikfarjam, Termeh Tarjoman, Abassali Nasehi, Firoozeh Jafari, Mohammad-Bagher Saberi-Zafarghandi

Affiliations

  1. Bureau of Mental & Social Health and Addiction, Ministry of Health, Treatment and Medical Education, Tehran, Iran.

PMID: 23967426 PMCID: PMC3744255

Abstract

BACKGROUND: The Ministry of Health, Treatment and Medical Education of Iran has recently announced an estimated figure of 200,000 injecting drug users (IDUs). The aim of this study was to pilot a national program using demographics, types of drug abuse and prevalence of blood-borne infections among IDUs.

METHODS: In order to elicit data on demographics, types of drug abuse and prevalence of blood-borne infections among IDUs, a questionnaire was designed in the Bureau of Mental-Social Health and Addiction in collaboration with Iran's Drug Control Headquarters of the Police Department. Therapeutical alliance of addiction in Shafagh Center was based on Methadone Maintenance Therapy (MMT).

RESULTS: Among 402 reported IDUs most of them were male, single and in age range of 20 to 39 years old with 72.7% history of imprisonment. Most of them had elementary and high school education and a history of addiction treatment. The majority were current users of opioid, heroin and crack. The prevalence of blood-borne infections was 65.9% and 18.8% for HCV and HIV/AIDS infections, respectively.

CONCLUSION: Prevention programs about harm reduction, treatment and counseling should include young IDUs as a core focus of their intervention structure.

Keywords: Harm reduction; IDUs; Iran; Methadone maintenance treatment

References

  1. Drug Alcohol Depend. 1995 Jun;38(3):255-9 - PubMed
  2. Arch Iran Med. 2010 Jul;13(4):318-23 - PubMed
  3. J Urban Health. 2009 Nov;86(6):902-8 - PubMed
  4. Drug Alcohol Depend. 2002 Jan 1;65(2):137-48 - PubMed
  5. J Urban Health. 2009 Jan;86(1):106-18 - PubMed
  6. PLoS One. 2011;6(8):e17502 - PubMed
  7. Arch Iran Med. 2008 Sep;11(5):553-4 - PubMed
  8. Addiction. 2007 Sep;102(9):1472-82 - PubMed
  9. Lancet. 2010 Mar 20;375(9719):1014-28 - PubMed
  10. BMC Public Health. 2012 Dec 11;12:1066 - PubMed
  11. J Acquir Immune Defic Syndr. 2002 Dec 1;31(4):422-31 - PubMed
  12. PLoS One. 2012;7(8):e42937 - PubMed
  13. Public Health Rep. 2002;117 Suppl 1:S135-45 - PubMed
  14. Braz J Infect Dis. 2009 Oct;13(5):356-8 - PubMed
  15. AIDS Care. 2002 Feb;14(1):77-93 - PubMed
  16. Lancet. 2011 Aug 13;378(9791):571-83 - PubMed
  17. Drug Alcohol Depend. 2006 Jun 28;83(2):147-56 - PubMed
  18. AIDS Behav. 2008 Jul;12(4 Suppl):S7-12 - PubMed
  19. J Urban Health. 2003 Mar;80(1):137-46 - PubMed
  20. Harm Reduct J. 2011 Jun 30;8:17 - PubMed
  21. J Urban Health. 2000 Sep;77(3):396-414 - PubMed
  22. Harm Reduct J. 2009 Jul 30;6:21 - PubMed
  23. J Public Health Policy. 2011 May;32(2):219-30 - PubMed
  24. Addiction. 1998 Apr;93(4):515-32 - PubMed
  25. Arch Iran Med. 2009 Sep;12(5):483-7 - PubMed
  26. MMWR Morb Mortal Wkly Rep. 2012 Mar 2;61(8):133-8 - PubMed
  27. Soc Sci Med. 2011 Oct;73(7):1097-104 - PubMed
  28. Lancet. 1999 Jan 16;353(9148):221-6 - PubMed
  29. Clin Infect Dis. 2001 Jul 15;33(2):240-7 - PubMed
  30. Int J Infect Dis. 2010 Jan;14(1):e28-33 - PubMed
  31. Harm Reduct J. 2006 Mar 18;3:12 - PubMed
  32. Drug Alcohol Depend. 2001 Feb 1;61(3):281-5 - PubMed
  33. Sex Transm Infect. 2005 Jun;81(3):279-80 - PubMed
  34. Sex Transm Infect. 2012 Apr;88(3):194-9 - PubMed

Publication Types